KOKenichi Okubo

Kenichi Okubo

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Kenichi Okubo has a total of 163 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    ASO Visual Abstract: Treatment for Oligo-recurrence of Diffuse Pleural Mesothelioma After Extended Pleurectomy/Decortication

    by Ryo Wakejima, Hironori Ishibashi, Ayaka Asakawa, Yuya Ishikawa, Yusuke Sugita, Kenichi Okubo

  • Treatment for Oligo-recurrence of Diffuse Pleural Mesothelioma After Extended Pleurectomy/Decortication

    by Ryo Wakejima, Hironori Ishibashi, Ayaka Asakawa, Yuya Ishikawa, Yusuke Sugita, Kenichi Okubo

    We evaluate recurrence patterns and assess the efficacy of local treatment for oligo-recurrence in patients with diffuse pleural mesothelioma (PM) followin

  • Open Access

    Postoperative routine computed tomography allows detection of early-stage acute exacerbations of interstitial pneumonia

    by Katsutoshi Seto, Yuya Ishikawa, Koichiro Kimura, Takuya Adachi, Ayaka Asakawa, Masashi Kobayashi, Hironori Ishibashi, Ukihide Tateishi, Kenichi Okubo

    Background: Postoperative acute exacerbation of interstitial pneumonia (IP-AE) is highly lethal after lung resection. Whether a symptom-free, routine computed tomography (rCT) can detect IP-AE early enough to justify pre-emptive steroids is unknown. We therefore aimed to assess the diagnostic accuracy of early postoperative rCT for detecting clinical IP-AE (cIP-AE) and to identify a high-specificity rCT score threshold that could support pre-emptive steroid treatment. Methods: This single-center, retrospective diagnostic-accuracy study analyzed 120 consecutive lung-cancer patients with underlying interstitial pneumonia (IP) who underwent high-resolution rCT within 7 days after surgery. Eligibility was based on preoperative high-resolution computed tomography (HRCT) demonstrating IP, irrespective of postoperative pathological confirmation. Two thoracic radiologists independently graded each scan on a five-point likelihood scale; a summed 10-point score (range, 2–10) was defined as the sum of the two readers’ five-point ratings, assigned retrospectively. Diagnostic accuracy was expressed as sensitivity, specificity, and area under the receiver operating characteristic (ROC) curve (AUC). The ROC analysis assessed the ability of the rCT score to detect cIP-AE. For analysis, the proposed treatment threshold was the lowest score, giving 100% specificity. Results: IP-AE developed in 14 patients (11.6%). The ROC for cIP-AE detection yielded an AUC of 0.956. A summed score ≥9 achieved 100% specificity and detected 36% of presymptomatic events, whereas ≥6 increased sensitivity (86%) but lowered specificity (89%). Five patients received steroid pulse therapy solely on the basis of rCT; four of the five scans scored ≥9 and one scored 8. Thirty- and 90-day mortality were 0.8% and 3.3%, respectively, and no grade ≥3 steroid-related toxicity occurred. Conclusions: A single rCT obtained within 1 week of lung resection can reveal radiological IP-AE (rIP-AE) before clinical decline. Using a score ≥9 confines early steroid treatment to patients with near-certain disease, avoiding unnecessary exposure. Prospective studies should confirm whether this high-specificity strategy improves survival and resource utilization.

  • Open Access

    Successful Treatment of Obstructive Pneumonia with Hemoptysis due to Non-Absorbable Suture-Related Granulation

    by Yukitaka Sato, Hironori Ishibashi, Ryota Ishizawa, Ayaka Asakawa, Kenichi Okubo

    INTRODUCTION: Non-absorbable sutures or Teflon pledgets (model number: 00801741041341, Bard, Franklin Lakes, NJ, USA) are sometimes used for protection of the bronchial stump to prevent bronchial fistula. However, there have been reports of foreign body-related bronchial granulation in the distant phase. Treatment of this rare complication is challenging, and there are no reports in the literature of cases that ultimately underwent curative surgical excision.CASE PRESENTATION: A 63-year-old man underwent a right lower lobectomy with ND2a-2 for typical pulmonary carcinoid 20 years ago. Twelve years after the operation, the right intermediate bronchus gradually became obstructed with granulation tissue from the right lower bronchial stump. Therefore, we eliminated the obstruction and placed a 2-cm Dumon stent (model number: 20300BZY00250000, Novatech SA, La Ciotat, France) in the intermediate bronchus. However, the inner lumen of the stent gradually became filled with the granulation tissue, and 6 years after the stenting, the patient was referred to the hospital owing to massive hemoptysis and obstructive pneumonia. Although transcatheter bronchial arterial embolization was performed for a pseudoaneurysm, blood-tinged sputum remained present, and aspiration pneumonia had spread to the right upper lobe. Bronchoscopy showed that a non-absorbable suture, which was used for the protection of the bronchial stump 20 years ago, was buried in the obstructive tissue. After antibiotic treatment for the pneumonia, we performed a right middle lobectomy as well as the removal of the stent and the threads as a curative treatment.CONCLUSIONS: Non-absorbable suture sometimes causes granulation tissue in the distant phase, and absorbable sutures are preferable for the bronchial stump. For the treatment, complete excision at an appropriate time is required based on the severity of the symptoms.

  • Open Access

    A Case of Induction Chemoimmunotherapy and Sleeve Lobectomy to Avoid Pneumonectomy for Central Squamous Cell Lung Cancer

    by Ayaka Asakawa, Ryota Ishizawa, Yukitaka Sato, Yuya Ishikawa, Ryo Wakejima, Hironori Ishibashi, Kenichi Okubo

    INTRODUCTION: Recently, neoadjuvant immunotherapy plus chemotherapy has been provided for patients with stage II-III resectable lung cancer. We report a case in which a pneumonectomy was avoided by administrating neoadjuvant chemoimmunotherapy.CASE PRESENTATION: An 81-year-old man presented with a cough. Examination showed squamous cell lung cancer in the right lower lobe extending to the central side of the upper lobe, which would have required a pneumonectomy for complete resection. Neoadjuvant chemoimmunotherapy was administered to reduce the extent of pulmonary resection due to the patient’s advanced age and impaired pulmonary function. Post-treatment examination showed tumor size reduction, and bronchoscopy showed disappearance of right upper bronchial erythema and persistent erythema of the bronchus intermedius. A sleeve right lower lobectomy was performed. Histopathological findings revealed complete resection of the cancerous lesion and a major pathological response.CONCLUSIONS: Sleeve lobectomy after preoperative chemoimmunotherapy for an elder patient with low pulmonary function was safe and efficient.


  • Open Access

    GPX4 and FSP1 Expression in Lung Adenocarcinoma: Prognostic Implications and Ferroptosis-Based Therapeutic Strategies

    by Hirotomo Takahara, Takumi Kanazawa, Haruna Oshita, Yoshinobu Tomita, Yuri Hananoi, Sachiko Ishibashi, Masumi Ikeda, Asuka Furukawa, Mayumi Kinoshita, Kurara Yamamoto, et al.

    Background: Primary lung cancer is among the cancers with the poorest prognosis, having the highest mortality rate among men and the second highest among women in Japan. While surgery is the primary treatment, advanced stages often require pharmacotherapy. Recently, ferroptosis, an iron-dependent form of cell death caused by lipid peroxidation, has gained attention as a potential therapeutic strategy. This study investigated the prognostic impact of lipid peroxidation marker and regulators involved in ferroptosis in lung adenocarcinoma. Methods: We analyzed 207 patients who underwent resection surgery for lung adenocarcinoma at Tokyo Medical and Dental University Hospital. Immunohistochemistry was used to evaluate the expression levels of glutathione peroxidase 4 (GPX4), ferroptosis suppressor protein 1 (FSP1), and 4-hydroxy-2-nonenal (4-HNE). The association between these markers and clinicopathological factors was assessed, and in vitro experiments were conducted to examine the effects of these markers on cell death. Results: Low cytoplasmic accumulation of 4-HNE and low expression of GPX4 were associated with a worse prognosis, and low FSP1 expression was associated with unfavorable relapse-free survival. In vitro experiments demonstrated that 4-HNE inhibited cell proliferation, and combined inhibition of GPX4 and FSP1 induced ferroptosis. Conclusions: These findings suggest that lipid peroxidation markers and regulators can serve as prognostic biomarkers and therapeutic targets in lung adenocarcinoma.


  • Open Access

    The Comprehensive Characterization of B7-H3 Expression in the Tumor Microenvironment of Lung Squamous Cell Carcinoma: A Retrospective Study

    by Ayaka Asakawa, Ryoto Yoshimoto, Maki Kobayashi, Nanae Izumi, Takanori Maejima, Tsuneo Deguchi, Kazuishi Kubota, Hisashi Takahashi, Miyuki Yamada, Sachiko Ishibashi, et al.

    Lung squamous cell carcinoma (LSCC) is refractory to various therapies for non-small cell cancer; therefore, new therapeutic approaches are required to improve the prognosis of LSCC. Although immunotherapies targeting B7 family molecules were explored as treatments for several cancer types, the expression and significance of B7-H3 in the tumor microenvironment (TME) and its relationship with other immune checkpoint molecules have not yet been investigated in detail. We used high-throughput quantitative multiplex immunohistochemistry to examine B7-H3 expression in the TME. We investigated the relationship between B7-H3 expression and prognosis as well as changes in the TME with B7-H3 expression using 110 surgically resected pathological specimens retrospectively. We examined the correlation between B7-H3 and programmed cell death-ligand 1 (PD-L1) expression in single cells. High B7-H3 expression in tumor cells was associated with a better prognosis and a significant increase in the number of CD163+PD-L1+ macrophages. Quantitative analysis revealed that there is a positive correlation between B7-H3 and PD-L1 expression in tumor and stromal cells, as well as in intratumoral tumor-infiltrating lymphocytes and tumor-associated macrophages in the same cells. CD68+, CD163+, and CK+ cells with PD-L1+ phenotypes had higher B7-H3 expression compared to PD-L1− cells. Our findings demonstrate a correlation between B7-H3 and PD-L1 expression in the same cells, indicating that therapies targeting B7-H3 could provide additional efficacy in patients refractory to PD-L1-targeting therapies.


  • Open Access

    Reconstruction of the Bifurcation of Right Upper Bronchus Using Miyamoto’s Technique for Typical Carcinoid

    by Ayaka Asakawa, Hironori Ishibashi, Kuniyo Sueyoshi, Erika Mori, Yasuhiro Nakashima, Masashi Kobayashi, Kenichi Okubo

    A 41-year-old woman presented with productive cough and exertional dyspnea. Bronchoscopy revealed an endobronchial tumor arising from the membrane proximal to the bifurcation of right upper bronchus, and the tumor was a typical carcinoid. The right main bronchus, right upper lobe bronchus, and intermediate bronchus were resected along with the tumor. Intraoperative pathological diagnosis of the bronchial stumps was negative, and bronchial reconstruction was subsequently performed. Two-thirds of the circumference of the right main bronchus and the right intermediate bronchus were anastomosed. The right upper lobe bronchus was anastomosed in an end-to-side fashion. The anastomotic site was covered by the intercostal muscles.


  • Open Access

    Excision of Giant Chronic Expanding Hematoma of the Thorax Caused by Rib Fractures after Proton Radiotherapy for Lung Cancer

    by Yukitaka Sato, Hironori Ishibashi, Yuki Funauchi, Kenichi Okubo

    Chronic expanding hematoma (CEH) is defined as a hematoma that gradually expands over months to years. An 82-year-old female underwent proton radiotherapy for left upper lobe lung cancer 10 years previously. Two years after the therapy, a hematoma developed from the left 3rd to 5th dorsal rib fractures and gradually expanded, causing contraction of the left shoulder. Transcatheter arterial embolization was performed; however, the hematoma continued to expand with thrombocytopenia, and the platelet was decreased to 4.2 × 104/μL. Computed tomography showed a 17.2 × 14.0 × 10.0 cm mass between the left scapula and left dorsal ribs. The CEH of the thorax was completely excised with combined resection of the 3rd to 5th ribs, while the brachial plexus was preserved. Postoperatively, the platelet completely recovered and she could raise her left arm. A complete excision with surrounding organs preserved is the strategy used in the treatment of CEH of the thorax.